Don’t miss the latest developments in business and finance.

Lupin gets final approval for Omeprazole Delayed-Release capsules 40 mg

Image
Capital Market
Last Updated : Aug 28 2015 | 12:05 AM IST

From USFDA

Lupin announced that it has received final approval for its Omeprazole Delayed-Release capsules 40 mg from the United States Food and Drugs Adminstration (FDA) to market a generic version of AstraZeneca Pharmaceuticals LP Prilosec Delayed-Release capsules 40 mg. It is indicated for the short term treatment of Duodenal Ulcer, Gastric Ulcer, treatment of Gastro Esophageal Reflux Disease (GERD), maintenance of healing of Erosive Esophagitis and Pathological Hypersecretory conditions.

Powered by Capital Market - Live News

Also Read

First Published: Aug 27 2015 | 6:15 PM IST

Next Story